1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsMTF Discretionary Fund is sponsored by Medical Toxicology Foundation (MTF). The MTF provides funding for a number of research grants for medical toxicologists and trainees, and travel scholarships for medical students and residents. This discretionary fund considers requests that do not fit within other established timeframes or guidelines.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
MTF Discretionary Fund - ACMT a total of $5,000 is available in 2026 The MTF provides funding for a number of research grants for medical toxicologists and trainees, and travel scholarships for medical students and residents. Occasionally, requests come to the MTF that do not fit in these timeframes or existing guidelines. The MTF has set up a small discretionary fund to consider these requests.
The maximum request amount is $5,000. Funding request examples could include: A survey of patients seen at your outpatient toxicology clinic is being considered as a follow-up to patient satisfaction surveys completed within your institution. Postage and statistician’s consultation are costs that your institution and department won’t cover for the 300 surveys being sent out.
Analysis at a reference laboratory of pooled de-identified plasma samples is needed as proof-of-concept before submitting a research proposal. Packaging and shipping costs from your hospital laboratory and reduced pricing from the reference laboratory are above your division’s funding ability.
An algorithm to assist residents in simulation toxicology training assessment of milestone accomplishment needs some help from computer programmers. While there has been interest from a number of developers, none have provided funding. Eligible applicants for the MTF Discretionary Fund are any ACMT member in good standing.
Please complete the project request form and email to foundation@acmt. net. Proposals will be reviewed and voted on by the MTF Board either at a regularly scheduled Board meeting or by email distribution.
If approved, recipients are required to submit a brief 1 year progress/completion report.
According to the current listing, eligibility includes: Medical toxicologists and trainees. Confirm the full requirements in the official notice before applying.
The current listing shows maximum $5,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
MTF Discretionary Fund is funded by Medical Toxicology Foundation (MTF). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read articleOn June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read article